Home › Funds › Point72 Asset Management › PHAT
Point72 Asset Management position in PHAT
PHATHOM PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)1.02M sh
Reported value held$11.09M
Portfolio Weight0.04%
First reportedQ1 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 11.51K | $82.15K | New |
| Q3 2024 | 439.82K | $7.95M | New |
| Q2 2026 | 1.02M | $11.09M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHAT
- Vanguard Group 3.18M sh · $52.71M · Q4 2025
- BlackRock Inc 4.53M sh · $49.10M · Q2 2026
- Invesco Ltd 4.03M sh · $43.72M · Q2 2026
- Millennium Management 3.38M sh · $36.63M · Q2 2026
- Franklin Resources 1.97M sh · $21.38M · Q2 2026
- Goldman Sachs Group 1.78M sh · $19.29M · Q2 2026
- Geode Capital Management 1.32M sh · $14.28M · Q2 2026
- Marshall Wace 666.09K sh · $7.23M · Q2 2026
- Two Sigma Investments 519.08K sh · $5.63M · Q2 2026
- Northern Trust Corp 458.30K sh · $4.97M · Q2 2026
- Charles Schwab Investment Management 419.09K sh · $4.55M · Q2 2026